HYFT supply chain intelligence for MindWalk Holdings Corp.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
MindWalk Holdings Corp. (HYFT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BCTX | BriaCell Therapeutics Corp. | 90% | On November 30, 2022, the Company's subsidiary, BioStrand entered into a research collaboration and license agreement with BriaCell Therapeutics Corp. |
| BCTX | BriaCell Therapeutics Corp. | 90% | Reciprocal relationship from BCTX graph: Reciprocal relationship from HYFT graph: On November 30, 2022, the Company's subsidiary, BioStrand entered into a research collaboration and license agreement… |
| OMNIAB-INC | OMNIAB-INC | 90% | On October 12, 2022, the Company's subsidiary, Talem entered into a multi-target license agreement with OmniAb, Inc. |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| JNJ | Johnson & Johnson | 72% | als. Moreover, in the past two years, the Company has gained increasing recognition as a rising leader in the biologics CRO space, with a focus on organic growth through market penetration and servic… |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from HYFT graph: als. Moreover, in the past two years, the Company has gained increasing recognition as a rising leader in the biologic… |
| ALDEVRON-LLC | ALDEVRON-LLC | 62% | brief biographies of our directors and executive officers. Dr. Jennifer Bath Dr. Bath is the CEO and President of IPA. She obtained a Ph.D. in Cellular and Molecular Biology, specializing in immunolo… |
| IMMP | Immutep Limited | 62% | Reciprocal relationship from IMMP graph: Reciprocal relationship from HYFT graph: ancing activities: Proceeds from share issuance, net of transaction costs 12 12,228 2,360 716 Proceeds from debenture… |
| MA-LLC | MA-LLC | 62% | ancing activities: Proceeds from share issuance, net of transaction costs 12 12,228 2,360 716 Proceeds from debenture 10 4,242 — — Repayment of principal on leases 11 ( 1,577 ) ( 1,339 ) ( 1,337 ) Ne… |
| NATURE-OF-OPERATIONS-IMMUNOPRECISE-ANTIBODIES-LT | NATURE-OF-OPERATIONS-IMMUNOPRECISE-ANTIBODIES-LT | 62% | ancing activities: Proceeds from share issuance, net of transaction costs 12 12,228 2,360 716 Proceeds from debenture 10 4,242 — — Repayment of principal on leases 11 ( 1,577 ) ( 1,339 ) ( 1,337 ) Ne… |
| N-D-LTD | N-D-LTD | 62% | ancing activities: Proceeds from share issuance, net of transaction costs 12 12,228 2,360 716 Proceeds from debenture 10 4,242 — — Repayment of principal on leases 11 ( 1,577 ) ( 1,339 ) ( 1,337 ) Ne… |
| ND-LTD | ND-LTD | 62% | business activities in Canada and a significant portion of the Company’s business activities depend on foreign operations in the Netherlands and the United States. The Company distributes and offers … |
| USA-LTD | USA-LTD | 62% | ancing activities: Proceeds from share issuance, net of transaction costs 12 12,228 2,360 716 Proceeds from debenture 10 4,242 — — Repayment of principal on leases 11 ( 1,577 ) ( 1,339 ) ( 1,337 ) Ne… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| HYFT-DEBT | Debt stack $2.6M | 90% | Market cache reports total debt of $2.6M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| HYFT-OWNER-IFP-ADVISORS-INC | IFP Advisors, Inc | 90% | 13F overlay lists IFP Advisors, Inc as top holder; 1 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | 100.00 | 2 | |
| ATON | AlphaTON Capital Corp | 100.00 | 2 | |
| BCAX | Bicara Therapeutics Inc. | 100.00 | 2 | |
| ACIU | AC Immune SA | 100.00 | 2 | |
| ANIK | Anika Therapeutics, Inc. | 100.00 | 2 | |
| AVBP | ArriVent BioPharma, Inc. | 100.00 | 2 | |
| ALC | Alcon Inc. | 100.00 | 2 | |
| CLGN | CollPlant Biotechnologies Ltd. | 100.00 | 2 | |
| ADGM | Adagio Medical Holdings, Inc. | 100.00 | 2 | |
| ABBV | AbbVie Inc. | 100.00 | 2 | |
| IMMP | Immutep Limited | 100.00 | 1 | ['customer'] |
| AORT | Artivion, Inc. | 100.00 | 2 | |
| BNR | Burning Rock Biotech Limited | 100.00 | 2 | |
| BNRG | Brenmiller Energy Ltd | 100.00 | 2 | |
| CYTOF | Altamira Therapeutics Ltd. | 100.00 | 2 | |
| CSTE | Caesarstone Ltd. | 100.00 | 2 | |
| BLLN | BillionToOne, Inc. | 100.00 | 2 | |
| ATRA | Atara Biotherapeutics, Inc. | 100.00 | 2 | |
| SNNUF | Smith & Nephew plc | 100.00 | 2 | |
| FDMT | 4D Molecular Therapeutics, Inc. | 100.00 | 2 |